TY - JOUR
T1 - Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity
AU - Ardehali, Hossein
AU - Chen, Zhenhui
AU - Ko, Young
AU - Mejía-Alvarez, Rafael
AU - Marbán, Eduardo
PY - 2004/8/10
Y1 - 2004/8/10
N2 - The mitochondrial ATP-sensitive K+ (mitoKATP) channel plays a central role in protection of cardiac and neuronal cells against ischemia and apoptosis, but its molecular structure is unknown. Succinate dehydrogenase (SDH) is inhibited by mitoKATP activators, fueling the contrary view that SDH, rather than mitoKATP, is the target of cardioprotective drugs. Here, we report that SDH forms part of mitoK ATP functionally and structurally. Four mitochondrial proteins [mitochondrial ATP-binding cassette protein 1 (mABC1), phosphate carrier, adenine nucleotide translocator, and ATP synthase] associate with SDH. A purified IM fraction containing these proteins was reconstituted into proteoliposomes and lipid bilayers and shown to confer mitoKATP channel activity. This channel activity is sensitive not only to mitoK ATP activators and blockers but also to SDH inhibitors. These results reconcile the controversy over the basis of ischemic preconditioning by demonstrating that SDH is a component of mitoKATP as part of a macromolecular super-complex. The findings also provide a tangible clue as to the structural basis of mitoKATP channels.
AB - The mitochondrial ATP-sensitive K+ (mitoKATP) channel plays a central role in protection of cardiac and neuronal cells against ischemia and apoptosis, but its molecular structure is unknown. Succinate dehydrogenase (SDH) is inhibited by mitoKATP activators, fueling the contrary view that SDH, rather than mitoKATP, is the target of cardioprotective drugs. Here, we report that SDH forms part of mitoK ATP functionally and structurally. Four mitochondrial proteins [mitochondrial ATP-binding cassette protein 1 (mABC1), phosphate carrier, adenine nucleotide translocator, and ATP synthase] associate with SDH. A purified IM fraction containing these proteins was reconstituted into proteoliposomes and lipid bilayers and shown to confer mitoKATP channel activity. This channel activity is sensitive not only to mitoK ATP activators and blockers but also to SDH inhibitors. These results reconcile the controversy over the basis of ischemic preconditioning by demonstrating that SDH is a component of mitoKATP as part of a macromolecular super-complex. The findings also provide a tangible clue as to the structural basis of mitoKATP channels.
UR - http://www.scopus.com/inward/record.url?scp=4143097031&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4143097031&partnerID=8YFLogxK
U2 - 10.1073/pnas.0401703101
DO - 10.1073/pnas.0401703101
M3 - Article
C2 - 15284438
AN - SCOPUS:4143097031
SN - 0027-8424
VL - 101
SP - 11880
EP - 11885
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 32
ER -